ACE and hepatocellular carcinoma: The last several decades have seen a plethora of studies on the utility of AFP and DCP in the surveillance and management of HCC, whereas there are only limited studies on the predictive and monitoring role of these two biomarkers in ICI-based therapeutics (43).